Detalhe da pesquisa
1.
Exagamglogene Autotemcel for Severe Sickle Cell Disease.
N Engl J Med;
390(18): 1649-1662, 2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38661449
2.
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
N Engl J Med;
386(7): 617-628, 2022 02 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34898139
3.
Betibeglogene Autotemcel Gene Therapy for Non-ß0/ß0 Genotype ß-Thalassemia.
N Engl J Med;
386(5): 415-427, 2022 02 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34891223
4.
Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing.
Am J Hematol;
99(3): 430-438, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38010293
5.
Defining curative endpoints for transfusion-dependent ß-thalassemia in the era of gene therapy and gene editing.
Am J Hematol;
99(3): 422-429, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38100154
6.
Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.
Am J Hematol;
98(1): 11-22, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36161320
7.
Who Places High Value on the Uterus? A Cross-sectional Survey Study Evaluating Predictors for Uterine Preservation.
J Minim Invasive Gynecol;
30(2): 131-136, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36332820
8.
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.
Blood;
136(5): 623-626, 2020 07 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32518950
9.
Development and validation of the Value of Uterus instrument and visual analog scale to measure patients' valuation of their uterus.
Am J Obstet Gynecol;
227(5): 746.e1-746.e9, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35764134
10.
Intermediate term outcomes after transvaginal uterine-preserving surgery in women with uterovaginal prolapse.
Int Urogynecol J;
33(7): 2005-2012, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34586437
11.
Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia.
N Engl J Med;
378(16): 1479-1493, 2018 04 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29669226
12.
A randomized controlled noninferiority trial of reduced vs routine opioid prescription after prolapse repair.
Am J Obstet Gynecol;
223(4): 547.e1-547.e12, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32199926
13.
Pelvic organ prolapse recurrence in young women undergoing vaginal and abdominal colpopexy.
Int Urogynecol J;
31(12): 2661-2667, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31828397
14.
Induction of Fetal Hemoglobin by Gene Therapy.
N Engl J Med;
384(3): 284-285, 2021 01 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33471981
15.
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
Blood;
129(11): 1548-1556, 2017 03 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27965196
16.
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
Am J Hematol;
99(4): 785-788, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38343182
17.
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.
Am J Hematol;
94(4): 446-454, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30637784
18.
Intraoral Digital Impression Technique for a Neonate With Bilateral Cleft Lip and Palate.
Cleft Palate Craniofac J;
56(8): 1120-1123, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30857398
19.
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Biol Blood Marrow Transplant;
24(7): 1313-1321, 2018 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29653206
20.
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
Biol Blood Marrow Transplant;
24(6): 1216-1222, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29374585